Sign up to our newsletter Subscribe
Understanding the Full Value of Long-Acting Therapies: less is more?
OHE Expert Profile
Grace Hampson
Associate Director
Grace is an economist with expertise in the methods and processes of value assessment, reimbursement and healthcare decision making. Her current research interests include interactions between health technology appraisal and novel payment mechanisms, particularly in relation to innovative technologies such as cell and gene therapies and new drugs to tackle Antimicrobial Resistance.
Grace is also interested in the economics of public health and nutrition and has recently completed an MSc in Nutritional Medicine at the University of Surrey.
Latest Publications
Challenges and Solutions for Budget Impact Analysis of Gene Therapies
Capturing the Broader Value of Antibiotics
Proposals for a Novel UK Antimicrobial Subscription Model: How Will Antibiotic Innovation be Scored?
Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective
Reimagining Prevention for a Healthier, More Prosperous Society
